192 related articles for article (PubMed ID: 4682321)
1. The effect of tumor size on concomitant tumor immunity.
Deckers PJ; Davis RC; Parker GA; Mannick JA
Cancer Res; 1973 Jan; 33(1):33-9. PubMed ID: 4682321
[No Abstract] [Full Text] [Related]
2. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
Milas L; Hunter N; Mason K; Withers HR
Cancer Res; 1974 Jan; 34(1):61-71. PubMed ID: 4809463
[No Abstract] [Full Text] [Related]
3. Host immunity to a growing transplanted methylcholanthrene-induced guinea pig sarcoma.
Cohen AM; Millar RC; Ketcham AS
Cancer Res; 1972 Nov; 32(11):2421-6. PubMed ID: 5082590
[No Abstract] [Full Text] [Related]
4. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation.
Jurin M; Suit HD
Cancer Res; 1974 Apr; 34(4):672-8. PubMed ID: 4814987
[No Abstract] [Full Text] [Related]
5. Tumor size and concomitant tumor immunity.
Deckers PJ; Davis RC; Mannick JA
Surg Forum; 1972; 23(0):112-4. PubMed ID: 4671043
[No Abstract] [Full Text] [Related]
6. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
BasombrÃo MA; Prehn RT
Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
[No Abstract] [Full Text] [Related]
7. Allograft immunity in the mouse. 1. Quantitation and specificity of cytotoxic effector cells after in vitro sensitization.
MacDonald HR; Phillips RA; Miller RG
J Immunol; 1973 Aug; 111(2):565-74. PubMed ID: 4123983
[No Abstract] [Full Text] [Related]
8. The specificity of concomitant tumor immunity at large tumor volumes.
Deckers PJ; Pardridge DH; Wang BS; Mannick JA
Cancer Res; 1976 Oct; 36(10):3690-4. PubMed ID: 953994
[TBL] [Abstract][Full Text] [Related]
9. Transfer of tumor-specific immunity with RNA: demonstration by immune cytolysis of tumor cells in vitro.
Ramming KP; Pilch YH
J Natl Cancer Inst; 1970 Sep; 45(3):543-53. PubMed ID: 5523195
[No Abstract] [Full Text] [Related]
10. Incorporation of 125-I-iododeoxyuridine into target cells as an assay for cell immunity.
Fish F; Yaakubovicz M; Witz IP
J Natl Cancer Inst; 1974 Dec; 53(6):1743-7. PubMed ID: 4436870
[No Abstract] [Full Text] [Related]
11. In vivo activity of in vitro immunized lymphocytes. I. Tumor allograft rejection mediated by in vitro activated mouse thymocytes.
Rouse BT; Wagner H; Harris AW
J Immunol; 1972 May; 108(5):1353-61. PubMed ID: 4623947
[No Abstract] [Full Text] [Related]
12. [Effect of different doses of cyclophosphamide on the immune response of mice with a methylcholanthrene-induced sarcoma].
Gordienko SP; Bergol'ts VM
Vopr Onkol; 1973; 19(11):54-60. PubMed ID: 4785975
[No Abstract] [Full Text] [Related]
13. Cell-mediated cytotoxicity: an assay using 125 I-iododeoxyuridine-labeled target cells.
Cohen AM; Burdick JF; Ketcham AS
J Immunol; 1971 Sep; 107(3):895-8. PubMed ID: 5572095
[No Abstract] [Full Text] [Related]
14. The effects of tumor bearing upon changes in cell distribution and membrane antigen characteristics in murine spleen and thymus cell subpopulations.
Konda S; Smith RT
Cancer Res; 1973 Aug; 33(8):1878-84. PubMed ID: 4541721
[No Abstract] [Full Text] [Related]
15. Discussion paper: in vitro augmentation of tumor immunity in a murine methylcholanthrene sarcoma system.
Yarlott MA; McKhann CF
Ann N Y Acad Sci; 1976; 277(00):533-40. PubMed ID: 187102
[No Abstract] [Full Text] [Related]
16. Immunity to a 3-methylcholanthrene-induced fibrosarcoma in the C57BL/6 mouse: in vivo analysis by the adoptive tumor neutralization test.
Poupon MF; Lespinats G; Kolb JP; Payelle B
J Natl Cancer Inst; 1979 Apr; 62(4):989-94. PubMed ID: 311871
[TBL] [Abstract][Full Text] [Related]
17. Effect of different cancer treatment methods on immunity to an antigenic transplantable murine fibrosarcoma (Meth A).
Khafagy M; Wanebo HJ; Alfieri A; Hahn EW
AJR Am J Roentgenol; 1977 Jun; 128(6):1027-9. PubMed ID: 414534
[No Abstract] [Full Text] [Related]
18. Tumor suppression by pyran copolymer: correlation with production of cytotoxic macrophages.
Harmel RP; zbar B
J Natl Cancer Inst; 1975 Apr; 54(4):989-92. PubMed ID: 1127729
[TBL] [Abstract][Full Text] [Related]
19. Immunologic enhancement in a syngeneic tumor system.
Beltz WR; Levy NL
Surg Forum; 1975; 26():142-4. PubMed ID: 1216091
[No Abstract] [Full Text] [Related]
20. The adoptive transfer of concomitant immunity to murine tumor isografts with spleen cells from tumor-bearing animals.
Deckers PJ; Edgerton BW; Thomas BS; Pilch YH
Cancer Res; 1971 Jun; 31(6):734-42. PubMed ID: 5088484
[No Abstract] [Full Text] [Related]
[Next] [New Search]
